[{"orgOrder":0,"company":"Nimble Science","sponsor":"IGY Immune Technologies & Life Sciences Inc.","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"","productType":"Dietary Supplement","year":"2024","type":"Inapplicable","leadProduct":"Igy Supplement","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Phase I","graph3":"Nimble Science","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nimble Science \/ IGY Immune Technologies & Life Sciences Inc.","highestDevelopmentStatusID":"6","companyTruncated":"Nimble Science \/ IGY Immune Technologies & Life Sciences Inc."},{"orgOrder":0,"company":"Nimble Science","sponsor":"University of Calgary","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"","productType":"Dietary Supplement","year":"2024","type":"Inapplicable","leadProduct":"Nutritional Supplement","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Phase I","graph3":"Nimble Science","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nimble Science \/ University of Calgary","highestDevelopmentStatusID":"6","companyTruncated":"Nimble Science \/ University of Calgary"},{"orgOrder":0,"company":"Nimble Science","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"","productType":"Dietary Supplement","year":"2024","type":"Inapplicable","leadProduct":"Milk","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Nimble Science","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nimble Science \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Nimble Science \/ Inapplicable"},{"orgOrder":0,"company":"Nimble Science","sponsor":"University of Calgary | Lallemand Health Solutions","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"","productType":"Probiotic","year":"2020","type":"Inapplicable","leadProduct":"Probiotic","moa":"Immune","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Nimble Science","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nimble Science \/ University of Calgary | Lallemand Health Solutions","highestDevelopmentStatusID":"1","companyTruncated":"Nimble Science \/ University of Calgary | Lallemand Health Solutions"},{"orgOrder":0,"company":"Nimble Science","sponsor":"LALLEMAND HEALTH SOLUTIONS","pharmaFlowCategory":"DU","therapeuticArea":"Gastroenterology","country":"","productType":"Probiotic","year":"2024","type":"Inapplicable","leadProduct":"Probiotic","moa":"Immune","graph1":"Gastroenterology","graph2":"Undisclosed","graph3":"Nimble Science","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Gastroenterology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nimble Science \/ Lallemand Health Solutions","highestDevelopmentStatusID":"1","companyTruncated":"Nimble Science \/ Lallemand Health Solutions"}]

Find Clinical Drug Pipeline Developments & Deals by Nimble Science

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          Boulder Peptide
                          Not Confirmed
                          Boulder Peptide
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Dietary Supplement

                          Upfront Cash : Inapplicable

                          November 25, 2024

                          Lead Product(s) : Nutritional Supplement

                          Therapeutic Area : Endocrinology

                          Highest Development Status : Phase I

                          Sponsor : University of Calgary

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          02

                          Boulder Peptide
                          Not Confirmed
                          Boulder Peptide
                          Not Confirmed

                          Lead Product(s) : Igy Supplement

                          Therapeutic Area : Undisclosed

                          Study Phase : Phase I

                          Sponsor : IGY Immune Technologies & Life Sciences Inc.

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Dietary Supplement

                          Upfront Cash : Inapplicable

                          November 22, 2024

                          Lead Product(s) : Igy Supplement

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Phase I

                          Sponsor : IGY Immune Technologies & Life Sciences Inc.

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          03

                          Boulder Peptide
                          Not Confirmed
                          Boulder Peptide
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Dietary Supplement

                          Upfront Cash : Inapplicable

                          May 01, 2024

                          Lead Product(s) : Milk

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Undisclosed

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          04

                          Boulder Peptide
                          Not Confirmed
                          Boulder Peptide
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Probiotic

                          Upfront Cash : Inapplicable

                          March 19, 2024

                          Lead Product(s) : Probiotic

                          Therapeutic Area : Gastroenterology

                          Highest Development Status : Undisclosed

                          Sponsor : LALLEMAND HEALTH SOLUTIONS

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          05

                          Boulder Peptide
                          Not Confirmed
                          Boulder Peptide
                          Not Confirmed

                          Lead Product(s) : Probiotic

                          Therapeutic Area : Undisclosed

                          Study Phase : Undisclosed

                          Sponsor : University of Calgary | Lallemand Health Solutions

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Probiotic

                          Upfront Cash : Inapplicable

                          July 28, 2020

                          Lead Product(s) : Probiotic

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Undisclosed

                          Sponsor : University of Calgary | Lallemand Health Solutions

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank